Baxter International Inc. (BAX)
$
23.87
+0.07 (0.29%)
Key metrics
Financial statements
Free cash flow per share
0.6491
Market cap
12.3 Billion
Price to sales ratio
1.1261
Debt to equity
1.3286
Current ratio
2.2964
Income quality
5.7955
Average inventory
2.3 Billion
ROE
-0.0212
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Baxter International Inc., through its subsidiaries, has developed a comprehensive portfolio of healthcare products that are distributed globally. The company reported an income before tax of -$289,000,000.00 showcasing its pre-tax profitability. Additionally, the company incurred an interest expense of $408,000,000.00 reflecting its debt servicing obligations. The income before tax ratio is -0.03 illustrating the pre-tax margin effectively. Among its offerings, Baxter provides a range of dialysis therapies, including peritoneal dialysis and hemodialysis, along with intravenous therapies, infusion pumps, and pharmacy compounding services. The EBITDA is $1,116,000,000.00 a key indicator of the company's operational profitability, which underscores its ability to generate earnings before interest, taxes, depreciation, and amortization. The company's stock is identified with the symbol 'BAX' in the market, reflecting its presence in various healthcare sectors. In addition to the core healthcare products, Baxter also supplies connected care solutions and patient monitoring technologies that aid in diagnosing and managing multiple health conditions. The stock is affordable at $23.87 suitable for budget-conscious investors looking for stable options. With a high average trading volume of 7,025,025.00 the stock indicates robust liquidity, attracting diverse investors. Baxter boasts a mid-range market capitalization of $12,260,133,270.00 demonstrating that the company is a steady performer in the healthcare landscape. It is a key player in the Medical - Instruments & Supplies industry, contributing significantly to the overall market landscape with its innovative solutions. Furthermore, it belongs to the Healthcare sector, driving innovation and growth across its service offerings. Thus, Baxter International Inc. not only provides essential healthcare products and services but also positions itself as an attractive investment opportunity with solid foundational metrics.
Is Baxter International Inc. (BAX) a good investment?
Investing in Baxter International Inc. (BAX) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C, with a Bullish outlook. Always conduct your own research before investing.
What is Baxter International Inc. (BAX)'s stock forecast?
Analysts predict Baxter International Inc. stock to fluctuate between $21.33 (low) and $40.05 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Baxter International Inc.'s market capitalization?
As of 2025-09-16, Baxter International Inc.'s market cap is $12,260,133,270, based on 513,621,000 outstanding shares.
How does Baxter International Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Baxter International Inc. has a Lower Market-Cap, indicating a difference in performance.
Does Baxter International Inc. pay dividends?
Baxter International Inc. pays dividends. The current dividend yield is 2.75%, with a payout of $0.17 per share.
How can I buy Baxter International Inc. (BAX) stock?
To buy Baxter International Inc. (BAX) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for BAX. Place an order (Market, Limit, etc.).
What is the best time to invest in Baxter International Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Baxter International Inc. stock ever split?
Baxter International Inc.'s last stock split was 1841:1000 on 2015-07-01.
How did Baxter International Inc. perform in the last earnings report?
Revenue: $10,636,000,000 | EPS: -$1.27 | Growth: -124.19%.
Where can I find Baxter International Inc.'s investor relations reports?
Visit https://www.baxter.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Baxter International Inc.?
You can explore historical data from here
What is the all-time high and low for Baxter International Inc. stock?
All-time high: $89.70 (2022-02-09) | All-time low: $21.33 (2025-08-01).
What are the key trends affecting Baxter International Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Baxter International (BAX) came out with quarterly earnings of $0.59 per share, missing the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.68 per share a year ago.
zacks.com
Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.
seekingalpha.com
Baxter International Inc. (NYSE:BAX ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair & Interim CEO Heather Knight - Executive Vice President & COO Joel T. Grade - Executive VP & CFO Conference Call Participants David Harrison Roman - Goldman Sachs Group, Inc., Research Division Lawrence H.
reuters.com
Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the lingering effect of Hurricane Helene, which damaged a key manufacturing facility and reduced demand for IV solutions.
zacks.com
BAX aims for modest Q2 growth as core segments build on Q1 momentum and margin gains stabilize after recent recovery.
businesswire.com
IRVING, Texas--(BUSINESS WIRE)--Vizient announced today the expansion of the Vizient Reserve Program to include IV fluids through a strategic partnership with Baxter.
businesswire.com
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on October 1, 2025, to stockholders of record as of August 29, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter At Baxter, we are everywhere healthcare happens – and everywhere it is going, with essential solutions in.
investopedia.com
Baxter International on Monday named Andrew Hider, chief executive of Canadian automation solutions firm ATS Corp., its new CEO.
reuters.com
Baxter International said on Monday that Andrew Hider will take over as the medical device maker's new Chief Executive Officer.
businesswire.com
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a member of its board of directors. Mr. Hider will assume his responsibilities at Baxter no later than Sept. 3, 2025, or an earlier date pending completion of his current employment commitments. Brent Shafer, who has served as chair and interim CEO since February 2025, will then transition to independ.
See all news
